Adavosertib found to delay tumour growth in some patients in clinical trial, with few side effects
Researchers have identified a potential new targeted treatment for incurable bowel cancer.
The medication has shown promise in a clinical trial in slowing the regrowth of tumours among some patients with the condition.
